Optical Options Of Valley Forge Llc | |
901 E 8th Ave, Ste 101, King Of Prussia, Pennsylvania 19406 | |
(610) 491-9272 |
Name | Optical Options Of Valley Forge Llc |
---|---|
Organization Name | Optical Options Of Valley Forge Llc |
Location | 901 E 8th Ave, Ste 101, King Of Prussia, Pennsylvania 19406 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (610) 491-9272 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
TaiGen Biotechnology Company, Limited today announced that the U.S. Food and Drug Administration has granted nemonoxacin (Taigexyn) Qualified Infectious Disease Product and Fast Track designations for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, announced initial patient enrollment in its DEEP AF feasibility trial. The first procedure was performed in a new, state-of-the-art hybrid room at Sentara Norfolk General Hospital in Norfolk, Virginia by Jonathan Philpott, M.D., Director of the Sentara Atrial Fibrillation Surgery Program, Ian Woollett, M.D., and John Onufer, M.D., Medical Director of Cardiac Electrophysiology.
Scientists have discovered what they believe has the potential to prevent the onset of an aggressive and hard-to-treat form of rheumatoid arthritis - a condition that affects 700,000 adults in the UK.
Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its next generation ACTONEL® (risedronate sodium) product for the treatment of postmenopausal osteoporosis in the United States. The product will be marketed as ATELVIA™ (risedronate sodium) delayed-release tablets.
› Verified 6 days ago
NPI Number | 1164569984 |
Organization Name | OPTICAL OPTIONS OF VALLEY FORGE LLC |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 901 E 8th Ave, Ste 101, King Of Prussia, PA 19406 |
Phone Number | 610-491-9272 |
News Archive
TaiGen Biotechnology Company, Limited today announced that the U.S. Food and Drug Administration has granted nemonoxacin (Taigexyn) Qualified Infectious Disease Product and Fast Track designations for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, announced initial patient enrollment in its DEEP AF feasibility trial. The first procedure was performed in a new, state-of-the-art hybrid room at Sentara Norfolk General Hospital in Norfolk, Virginia by Jonathan Philpott, M.D., Director of the Sentara Atrial Fibrillation Surgery Program, Ian Woollett, M.D., and John Onufer, M.D., Medical Director of Cardiac Electrophysiology.
Scientists have discovered what they believe has the potential to prevent the onset of an aggressive and hard-to-treat form of rheumatoid arthritis - a condition that affects 700,000 adults in the UK.
Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its next generation ACTONEL® (risedronate sodium) product for the treatment of postmenopausal osteoporosis in the United States. The product will be marketed as ATELVIA™ (risedronate sodium) delayed-release tablets.
› Verified 6 days ago
News Archive
TaiGen Biotechnology Company, Limited today announced that the U.S. Food and Drug Administration has granted nemonoxacin (Taigexyn) Qualified Infectious Disease Product and Fast Track designations for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, announced initial patient enrollment in its DEEP AF feasibility trial. The first procedure was performed in a new, state-of-the-art hybrid room at Sentara Norfolk General Hospital in Norfolk, Virginia by Jonathan Philpott, M.D., Director of the Sentara Atrial Fibrillation Surgery Program, Ian Woollett, M.D., and John Onufer, M.D., Medical Director of Cardiac Electrophysiology.
Scientists have discovered what they believe has the potential to prevent the onset of an aggressive and hard-to-treat form of rheumatoid arthritis - a condition that affects 700,000 adults in the UK.
Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its next generation ACTONEL® (risedronate sodium) product for the treatment of postmenopausal osteoporosis in the United States. The product will be marketed as ATELVIA™ (risedronate sodium) delayed-release tablets.
› Verified 6 days ago
Boston Orthotics & Prosthetics Type: Prosthetic/Orthotic Supplier Location: 1150 1st Ave, King Of Prussia, Pennsylvania 19406 Phone: (484) 681-9205 | |
Children's Hospital Home Care Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3000 Horizon Dr, King Of Prussia, Pennsylvania 19406 Phone: (800) 866-1242 | |
Giant Pharmacy 6512 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 310 S Henderson Road, King Of Prussia, Pennsylvania 19406 Phone: (610) 290-1031 | |
Hanger Clinic Type: Durable Medical Equipment & Medical Supplies Supplier Location: 700 S Henderson Rd, King Of Prussia, Pennsylvania 19406 Phone: (484) 685-3645 | |
Lenscrafters #05653 Type: Eyewear Supplier (Equipment, not the service) Location: 160 N Gulph Rd, King Of Prussia, Pennsylvania 19406 Phone: (610) 962-5945 |